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Amplified Fragment Length Polymorphism (AFLP) profiling was used to evaluate the distribution of 
phenotypically indistinguishable, but genetically distinct, among Campylobacter concisus strains from 
South Africa. A Polymerase Chain Reaction (PCR) assay described for identifying strains belonging to 
Genomospecies 1 and 2 was applied in this study. Forty-seven C. concisus strains were studied in 
total, of which 42 were of South African origin. Forty of the South African isolates were assigned to the 
major existing genomospecies typified by the type strain of oral origin (GS1), and reference strains 
from bloody diarrhoea (GS2). Eighteen South African isolates were distributed in the GS1 cluster 
including two oral strains. Twenty-two faecal South African isolates clustered with reference GS2 
strains. Two novel genomospecies (GS 5 and 6) were inferred by their AFLP profile characteristics. 
Use of an existing PCR assay first described for identification of GS1 and GS2 strains generally 
indicated that the tool was accurate, although the novel genomospecies described here yielded an 
amplicon in the GS2 assay. No consistent clinical pattern among the diarrhoea South African strains 
could be discerned. The study extends the known genetic diversity among C. concisus, elucidates the 
presence of multiple genomospecies in South Africa, and confirms for the first time an association of 
GS1 with diarrhoea as well as the utility (with caveats) of a PCR assay for identifying GS1 and GS2 
strains. 
 
Key words: AFLP, Campylobacter concisus strains, bloody diarrhoea, genomospecies, PCR. 
 
 
INTRODUCTION 
 
Campylobacter concisus was described in 1981 having 
been recovered from oral specimens of patients with 
periodontal disease (Tanner et al., 1981). Since this initial 
description, various studies have demonstrated it to be 
associated with cases of human gastroenteritis 
(Vandamme et al., 1989; Lastovica, 2006; Cornelius et
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al., 2012; Nielsen et al., 2012). In most of these 
investigations, the prevalence of C. concisus rivals that of 
the entero-pathogenic species C. jejuni, now well 
established as the most frequent bacterial cause of 
gastroenteritis worldwide (Olson et al., 2008). However, 
studies of C. concisus have been hampered since most 
culture methods used routinely are poorly suited for its 
recovery (Lastovica, 2006). 
Although the use of more suitable methods (principally 
"the Cape Town protocol", or variants thereof) have 
frequently shown C. concisus to be prevalent in diarrhoea 
(Lastovica, 2006; Nielsen et al., 2012), its clinical 
significance is as yet unproven, since it has been shown 
to be as frequently detected in healthy stools as 
diarrhoea ones (Van Etterijck et al., 1996; Cornelius et 
al., 2012). One explanation for this apparent conundrum 
has been the characterisation of C. concisus as a highly 
diverse species-complex that comprises several 
genomospecies (GS): phenotypically indistinguishable, 
yet genetically distinct, species that may differ in their 
pathogenic potential (Vandamme et al., 1989; Aabenhus 
et al., 2005; Kalischuk and Inglis, 2011). The application 
of a high-resolution genotyping method, Amplified 
Fragment Length Polymorphism (AFLP) profiling 
(Aabenhus et al., 2005) identified four genomospecies. A 
subsequent study of some pathogenic characteristics of 
GS1 and GS2 strains revealed that GS1 strains (that 
include the type strain of oral origin) exhibited lower 
levels of epithelial invasion and translocation than GS2 
isolates (Kalischuk and Inglis, 2011), an observation 
consistent with known roles for these factors in diarrhoeal 
disease. 
At the Red Cross Children’s hospital, the long-standing 
use of “The Cape Town Protocol” (Lastovica, 2006), 
which is well suited to the recovery of a wider range of 
Epsilonproteo-bacterial species (including the genera 
Campylobacter, Arcobacterand Helicobacter) has 
resulted in consistent reports of high prevalence of C. 
concisus in, particularly, paediatric diarrhoea cases 
(Lastovica, 2006). The genetic diversity of South African 
C. concisus strains has been demonstrated in a study 
using NotI– based macro-restriction profiling (Matsheka 
et al., 2002), but this method does not allow for the 
classification of strains into genomospecies. In this study, 
we examine a range of C. concisus isolates of South 
African origin using AFLP profiling, to obtain a snapshot 
of the distribution of GS in this locality. These results are 
also used as the basis for a study of the specificity of 
PCR assays originally designed to identify strains of GS1 
and GS2 (Bastyns et al., 1995), but developed prior to 
the identification of additional genomospecies (Aabenhus 
et al., 2005). 
 
 
MATERIALS AND METHODS 
 
Bacterial strains 
 
A total of 47 C. concisus isolates were studied (Table  1).  Forty-two  
 
 
 
 
were field isolates from the Red Cross Children’s Hospital in Cape 
Town that had been characterised previously by macro-restriction 
profiling (Matsheka et al., 2002). Clinical details, including stool 
white blood cell count and co-infections known, are also given in 
Table 1. Representatives of the four genomospecies, identified 
previously by AFLP (Aabenhus et al., 2005), included the type 
strain of oral origin (CCUG 13144
T
: GS1), CCUG 19995 and 13826 
(GS2), 7656 (GS3) and 13570 (GS4).  
 
 
AFLP profiling 
 
DNA was extracted from three-day old bacterial cultures, and 
subjected to AFLP profiling, as described previously (Aabenhus et 
al., 2005). In brief, ca. 625 ng of genomic DNA from each isolate 
was digested simultaneously with 1 U of MfeI and 1 U of BSpDI in 
NEB4 buffer (New England Biolabs Ltd.), in a total reaction volume 
of 20 µl. Ligation was performed directly in the restriction digestion 
by adding 1 U of T4 DNA ligase, 2 µl of 10X T4 DNA ligase buffer 
(USB Corporation, Cleveland, Ohio), 2 µM MfeI (5’ 
AATTCCAAGAGCTCTCCAGTAC 3’ and 5′ 
TAGTACTGGAGAGCTCTTGG 3) and 20 µM BSpDI adapters (5′-
CAG GTA TCG CCG AGT TTA GAC A-3’ and 5′-CGT GTC TAA 
ACT CGG CGA TAC-3’) complementary to the respective restriction 
sites. The final volume was adjusted to 40 µl, and ligation was 
performed at 37°C for 3 h. The digestion-ligation was subsequently 
diluted by the addition of 960 µl of Milli-Q H2O. PCR was performed 
with 5 µl of the diluted digestion-ligation mixture. The PCR primer 
sequences were MfeI-F, synonymous with BGL2F-0 (5’ GAG AGC 
TCT TGG AAT TG 3’; 6-carboxylfluorescein labeled at the 5’ end); 
and BspDI, (5’ GTG TAC TCT AGT CCG AT 3’) (DNA Technology, 
Århus, Denmark). The number of cycles used was 25. AFLP 
fragments were detected with an ABI 377 automated sequencing 
machine (Amersham Biosciences AB, Uppsala, Sweden) as 
previously described (26) and processed with GeneScan, version 
3.1 (Applied Biosystems, Foster City, Calif.). AFLP profiles were 
then exported, assimilated into a database and compared using the 
program Bionumerics 5.1 (Applied Maths, Kortrijk, Belgium). A 
dendrogram of inter-strain relationships was produced using the 
Dice coefficient and UPGMA clustering as described before 
(Aabenhus et al., 2005). 
 
 
Genomospecies-specific PCR analysis 
 
A subset of South African isolates, and type and reference strains 
of GS1 and GS2, was examined using the assay described by 
Bastyns et al. (1995). PCR amplification of the specific C. concisus 
23S rRNA gene regions was performed as described by these 
authors, except that the two reverse primers were used 
independently (Kalischuk and Inglis, 2011). Briefly, genomic DNA 
was prepared from each isolate using the DNeasy Blood  and 
Tissue Kit (Qiagen Inc., Valencia, CA, USA) as per manufacturer’s 
instructions for Gram-negative bacteria. PCR reactions were 
prepared containing the following:  100 ng genomic DNA, 1.5 mM 
MgCl2, 1 X PCR Buffer II (Applied Biosystems, Foster City, CA, 
USA), 0.2 mg/ml BSA, 250 uM each dNTP, 200 µM MUC1 forward 
primer, 200 µM CON1 reverse primer or 200 µM CON2 reverse 
primer and 1.25 U AmplitaqTaq DNA polymerase (Applied 
Biosystems). PCR amplification was performed using  a GeneAmp
®
 
PCR System 9600 thermo-cylcer with the following cycling 
conditions:  94°C for five minutes, followed by 30 cycles of 94°C for 
60 s, 60°C for 60 s,  72°C for 60 s, followed by  72°C for 5 min. 
PCR amplicons were analyzed by a MCE-202 Multi-NA Microchip 
Electrophoresis System (Shimadzu Corporation, Kyoto, Japan) 
using standard operating procedures for on-chip mixing with the 
DNA 500 Reagent Kit (Shimadzu); detection was performed using 
SYBR  Gold  (Invitrogen  Corporation,   Carlsbad,   CA,   USA)   and  
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Table 1. Strain details. All strains from South Africa unless otherwise stated. CCUG, Culture Collection of the University of Gothernburg, 
Sweden. 
 
Strain 
no. 
Clinical details 
Patient 
sex 
Patient 
age 
(months) 
Co-isolations 
Stool 
WBC 
Stool 
RBC 
AFLP Cluster / 
Genomospecies 
assignation 
PCR – based 
identification 
45.99 
Persistent loose 
stools 
M 12 None 0 0 1 1 
15.99 HIV + diarrhoea M 7 Ascaris spp. 2 0 1 1 
38.99 
Protein-losing 
enteropathy 
M 13 None ND ND 1  
205.94 Bloody diarrhoea F 21 None 1 2 1  
220.96 Dysentery M 9 None 1 0 1 1 
D9 Adult, dental F 384 N/A NA NA 1  
61.99 Dysentery M 12 
Shigella 
dysenteriae 
3 2 1 1 
64.99 Dysentery F 27 None 1 0 1 1 
219.96 Chronic diarrhoea F 11 None 0 0 1  
CCUG 
13144
T
 
Adult, gingivitis, 
USA 
NA NA  NA NA NA 1 1 
115.99 Aplastic anaemia M 3 None 0 ND 1 1 
24.99 Fever, ventilated F 40 None 0 0 1 1 
389.96 Chronic diarrhoea F 20 None 0 0 1 1 
28.99 Dysentery F 14 None 0 0 1 1 
12.99 
Recent history of 
worms 
F 30 
Not at time of 
examination 
0 0 1  
204.93 Chronic diarrhoea M 9 None 0 0 1  
26A Adult, dental M 336 NA NA NA 1  
396.96 
Pneumonia, 
diarrhoea + vomiting 
F 6 None 0 0 1  
312.98 Chronic diarrhoea M 6 None 1 0 2 2 
47.99 Gastroenteritis M 15 None 0 0 2  
331.98 Bloody diarrhoea F 18 None 1 1 2  
207.94 Chronic gastritis M 3 None 0 0 2  
25.99 Chronic diarrhoea M 19 Ascaris spp. 0 3 2  
20.93 Biliary atresia M 6 None 1 0 2  
59.99 Chronic diarrhoea F 9 None 1 0 2  
62.99 Chronic diarrhoea F 13 None 0 0 2  
CCUG 
19995 
Faeces, patient with 
pyrexia & 
exanthema, Sweden 
NA NA NA  NA NA 2 2 
318.98 HIV + bloody stools M 21 None 1 2 2  
113.99 Prolonged diarrhoea F 15 
Cryptosporidium 
spp. 
1 0 2 2 
25.94 Microcytic anaemia F 24 Ascaris spp. 1 0 2  
135.99 Malabsorption F 6 
Shigella 
dysenteriae 
1 3 2 2 
122.99 Dysentery F 9 None 0 1 2  
130.99 Diarrhoea M 9 None 2 0 2  
377.96 Dysentery F 5 None 2 2 2 2 
131.99 Dysentery F 25 Shigella flexneri 3 3 2 2 
140.99 Dysentery F 17 None ND ND 2 2 
35.99 Diarrhoea F 11 
Cryptosporidium 
spp. 
0 0 2  
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Table 1. Continued. 
 
275.95 
Rectal prolapse, 
diarrhoea 
F 39 Trichuris spp. 0 0 2 2 
104.93 Loose stools F 29 None 1 0 2 2 
316.98 Bloody diarrhoea M 4 Shigella flexneri 3 1 2 2 
305.98 Dysentery F 17 None 1 0 2  
306.98 
Hirschprung´s 
disease 
M 19 None 1 0 2  
RH 
13826 
Bloody stool, 
Denmark 
UN 324 UN ND ND 2  
RH 
7656 
Diarrhoea, insulin-
dependant 
diabetes mellitus 
patient, Denmark 
UN 540  UN ND ND 3  
RH 
13570 
Diarrhoea, patient 
with liver abscess, 
Denmark 
UN 552  UN ND ND 4  
127.99 Chronic diarrhoea M 7 None 0 0 5 2 
393.96 
Loose mucoid 
stools 
F 5 None 1 0 6 2 
 
RH, Rigshospitalet, Denmark; M, male; F, female; ND, not done; NA, not applicable; T, type strain; UN, unknown.  
 
 
 
amplicon sizing was determined by comparison to a 25 bp DNA 
ladder (Invitrogen). Analysis of Multi-NA data was performed using 
the Multi-NA Viewer Software (Shimadzu).  
 
 
RESULTS 
 
AFLP typing of C. concisus 
 
The AFLP profiles of the 47 isolates examined contained 
2 – ca. 50 fluorescently-labelled fragments in the 50 – 
500 bp detection range (Figure 1).  Reproducibility was 
evaluated by examining 19 strains on different occasions 
and subsequent cluster analysis of the AFLP profiles 
(data not shown). The mean similarity (S-) values 
obtained between duplicates was 92.0%. 
AFLP analysis revealed a high level of genetic diversity 
among the strains, with no two profiles alike. Cluster 
analysis of the profiles delineated six clusters at the 
18.0% S-level (Figure 1). Clusters 1, 2, 4 and 5 contained 
the type and reference strains designated previously as 
Genomospecies 1-4, respectively. Clusters 3 and 6 were 
represented by single South African isolates (Lasto 
127.99 and Lasto 393.96, respectively) with AFLP 
patterns distinct from those studied previously. South 
African strains representing GS 3 or 4 were not identified 
in this study. However, 17 isolates from the region were 
identified as C. concisus GS1, and 23 as GS2, on the 
basis of the AFLP cluster analysis.  
 
 
Clinical data 
 
With the exception of one (D9), all South African  isolates  
were from faecal samples from children, 15 of which 
suffered from co-infections and/or other underlying 
conditions (Table 1). The adult dental isolate was 
confirmed as C. concisus GS1. We believe our study is 
the first to identify a GS1 strain (205.94) associated with 
bloody diarrhoea, a condition hitherto only associated 
with GS2 infection. However, no consistent clinical 
pattern among the diarrhoeal South African isolates of 
the four C. concisus genomospecies could be discerned 
(Table 1). 
 
 
Genomospecies-specific PCR assay results 
 
Twenty South African isolates and type and reference 
strains representing C. concisus GS1 (CCUG 13144
T
) 
and GS2 (CCUG 19995) were examined with the 
genomospecies-specific assay described previously 
(Bastyns et al., 1995). Strains assigned to GS1 and GS2 
on the basis of the cluster analysis of their AFLP profiles 
were similarly identified as GS1 and GS2 in the PCR 
assay (Table 1). However, two South African strains 
assigned to novel genomo-species 5 and 6 on the basis 
of their AFLP profiles (Lasto 127.99 and Lasto 393.96: 
Figure 1) yielded an amplicon in the GS2 PCR assay 
(Bastyns et al.,1995) (Table 1). 
 
 
DISCUSSION 
 
As with previous studies using AFLP (Aabenhus et al., 
2005; Kalischuk and Inglis, 2011), PFGE (Matsheka et 
al., 2002) and Multi-Locus Sequence Typing (Miller et al.,  
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Figure 1. AFLP profile analysis of C. concisus strains studied. Six clusters are 
defined at the 18.0% S-level that correspond to known and novel genomospecies. 
 
 
 
2012), the C. concisus strains examined in this study 
displayed a high genetic diversity, with each strain 
yielding a unique AFLP profile. Of the Campylobacter 
species for which DNA-based subtyping has been 
undertaken on appreciable numbers of strains, C. 
concisus appears to be the most polymorphic. 
Interestingly, despite the apparent lack of clonality as 
inferred in AFLP (Aabenhus et al., 2005; Kalischuk and 
Inglis, 2011; this study) or MLST analysis (Miller et al., 
2012), the latter has not yet identified substantive 
recombination events between strains. Additional work is 
needed to resolve the population genetics of this 
intriguing species. 
Despite the apparent lack of clonality  between  strains,  
groupings of patterns based around established 
genomospecies could be seen. As in previous studies 
(Aabenhus et al., 2005; Kalischuk and Inglis, 2011), two 
major groups were revealed, that corresponded to GS1 
(that includes CCUG 13144, the type strain of oral origin) 
and GS2 (that includes reference strains CCUG 19995 
and RH 13826 from human gastroenteritis). No 
appreciable similarity between South African isolates was 
obtained with reference profiles of GS3 (RH 7656) and 
GS4 (RH 13570; which was indicated by MLST to be C. 
curvus: Miller et al. (2012). On the other hand, two 
profiles were observed, that were highly distinctive and 
occupied well separated positions in the dendrogram, 
and  potentially  representing  new  C. concisus  genomo-  
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species (GS 5 and 6 respectively). Additional work is, 
however, required to substantiate this suggestion. 
Aabenhus and colleagues (2005) observed a 
statistically significant correlation between the prevalence 
of GS2 strains in immune-competent patients not infected 
with other gastrointestinal pathogens that, together with 
the finding that bloody stools were only found in cases of 
GS2 infection and the tendency for GS2 strains to be 
more frequently associated with fever exceeding 38°C, 
led the authors to propose that GS2 strains were more 
invasive and aggressive than GS1 isolates. Similar 
results were described in a Canadian study (Kalischuk 
and Inglis, 2011) in which AFLP cluster 2 strains 
(equivalent to our GS2 designation) demonstrated 
increased invasion and translocation abilities in in vitro 
assays, and were more frequently associated with 
diarrhoea, than AFLP cluster 1 (that included the oral 
type strain and equivalent to our GS1 designation) 
isolates. However, our results differ somewhat from the 
Danish and Canadian studies (Aabenhus et al., 2005; 
Kalischuk and Inglis, 2011), in both the study population 
demographic (where our focus was on paediatric cases) 
and the genomospecies associations. Although our oral 
isolates were identified as GS1, and three of four strains 
associated with bloody stools identified as GS2, we 
believe our study is the first to demonstrate C. concisus 
GS1 can be associated with bloody diarrhoea. Another 
important distinction between our study and that of 
Aabenhus and colleagues (2005) is the prevalence of co-
infections among gastroenteritis cases containing GS1 or 
GS2. In the current study, other enteric pathogens 
(including Shigella, Cryptosporidium and Ascaris spp.) 
were detected in only 2 of 15 GS1 (13%) diarrhoea 
cases, but the corresponding data for GS2 diarrhoea 
cases was 8 of 23 (35%). Using a Fishers Exact Test, 
there is no significant difference between these groups 
(p=0.26). Elevated stool WBC counts are indicative of 
active infections, while those with raised RBC are used to 
diagnose conditions such as Crohn’s Disease, ulcerative 
colitis and cancer. Again, the Fishers Exact Test revealed 
no statistically significant differences in our observations 
of elevated levels of either marker between GS1and GS2 
infections. It should also be noted that technical and fiscal 
limitations in the present study precluded stool analysis 
for norovirus and rotavirus; however even with that 
limitation, our study indicates that the pathogenic 
potential of the major C. concisus genome-species 
remains complex. This is ratified by a recent study 
(Kaakoush et al., 2011), in which C. concisus strains 
containing a plasmid or the exotoxin 9 gene, 
demonstrated a higher invasive potential than those 
lacking this characteristic and were recovered only from 
patients with chronic gastrointestinal illness (including 
Crohn’s Disease). 
In addition, pathogenic characteristics including 
haemolytic activity, induction of DNA apoptosis, and toxin 
gene  carriage  have  been  determined  in   GS1   strains  
 
 
 
 
(Kalischuk and Inglis, 2011). 
The fastidious nature, taxonomic complexity and lack of 
validated tools for identification of C. concisus 
genomospecies have significantly limited studies of this 
organism, despite various investigations showing it to be 
frequently associated with gastrointestinal illness. Recent 
developments including AFLP and MLST analyses have 
proven to be effective discriminatory tools, but are 
complex for routine use. For that reason, we performed a 
limited comparison of our AFLP results with those of a 
simple PCR described in 1995 to distinguish GS1 and 
GS2 isolates (Bastyns et al., 1995). We found an 
excellent correlation with C. concisus genomospecies 
identification between these two approaches, although 
the novel genome-species (GS5 and GS6) we describe 
would be identified as GS2 according to the PCR assay 
(Table 1). However, MLST analysis of the GS5 strain 
places it in a cluster dominated by known GS2 strains 
(Miller et al., 2012). This may indicate that the PCR assay 
correlates more accurately with more distant strain 
phylogenetic relationships than recent evolutionary 
events detected by those more finely resolved by AFLP. 
This is not entirely surprising, given that the PCR design 
was from 23S rRNA gene sequence data, an important 
phylogenetic marker. More work is needed to clarify this, 
but we believe our data validates the use of the simple 
PCR in further investigations by clinical laboratories 
aimed at clarifying the role and significance of the major 
genomospecies of this ubiquitous, yet poorly understood 
Campylobacter. 
In conclusion, this study extends the known genetic 
diversity among C. concisus, elucidates the presence of 
multiple genomospecies in South Africa, and confirms for 
the first time an association of GS1 with diarrhoea as well 
as the utility (with caveats) of a PCR assay for identifying 
GS1 and GS2 strains. Given recent studies 
demonstrating C. concisus is present in well established 
vectors of disease, namely domestic pets (Petersen et 
al., 2007) and poultry and beef samples (Lynch et al., 
2011), further studies of this organism are certainly 
warranted. 
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